Celestino Sardu
Overview
Explore the profile of Celestino Sardu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
4465
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Caturano A, Nilo R, Nilo D, Russo V, Santonastaso E, Galiero R, et al.
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065795
Diabetes mellitus, which comprises a group of metabolic disorders affecting carbohydrate metabolism, is characterized by improper glucose utilization and excessive production, leading to hyperglycemia. The global prevalence of diabetes is...
12.
Sardu C, Vittoria Marfella L, Giordano V, Lepre C, DAmico G, Volpicelli M, et al.
Front Pharmacol
. 2024 Jun;
15:1402782.
PMID: 38835659
Background: Left bundle branch (LBB) pacing could achieve cardiac resynchronization therapy (CRT) in patients who cannot be resynchronized via the placement of the left ventricle (LV) lead into the coronary...
13.
Anastasio C, Donisi I, Del Vecchio V, Colloca A, Mele L, Sardu C, et al.
Cell Mol Biol Lett
. 2024 May;
29(1):80.
PMID: 38811901
Background: Sodium-glucose transporter 2 (SGLT2) inhibitors (iSGLT2) are approved medications for type 2 diabetes. Recent studies indicate that iSGLT2 inhibit the growth of some cancer cells. However, the mechanism(s) remains...
14.
Galiero R, Loffredo G, Simeon V, Caturano A, Vetrano E, Medicamento G, et al.
PLoS One
. 2024 May;
19(5):e0296495.
PMID: 38713731
Background & Aims: SARS-Cov-2 infection manifests as a wide spectrum of clinical presentation and even now, despite the global spread of the vaccine, contagiousness is still elevated. The aim of...
15.
Fumagalli C, Ponti L, Smorti M, Pozza F, Argiro A, Zampieri M, et al.
Aging Clin Exp Res
. 2024 Apr;
36(1):89.
PMID: 38598143
Background: Whether, and to what extent, frailty and other geriatric domains are linked to health status in patients with transthyretin cardiac amyloidosis (ATTR-CA) is unknown. Aims: To determine the association...
16.
Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, et al.
N Engl J Med
. 2024 Mar;
390(10):900-910.
PMID: 38446676
Background: Microplastics and nanoplastics (MNPs) are emerging as a potential risk factor for cardiovascular disease in preclinical studies. Direct evidence that this risk extends to humans is lacking. Methods: We...
17.
Caturano A, Galiero R, Vetrano E, Medicamento G, Alfano M, Beccia D, et al.
Life (Basel)
. 2024 Jan;
14(1).
PMID: 38255701
Background And Aims: The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has fundamentally reshaped the landscape of global public health, with some people suffering more adverse clinical outcomes than...
18.
Martino E, DOnofrio N, Balestrieri A, Colloca A, Anastasio C, Sardu C, et al.
Nutrients
. 2024 Jan;
16(1).
PMID: 38201989
In the context of nutrient-driven epigenetic alterations, food-derived miRNAs can be absorbed into the circulatory system and organs of recipients, especially humans, and potentially contribute to modulating health and diseases....
19.
Marfella R, Prattichizzo F, Sardu C, Rambaldi P, Fumagalli C, Vittoria Marfella L, et al.
Cardiovasc Diabetol
. 2024 Jan;
23(1):10.
PMID: 38184582
Background: Few studies explored the effect of the combination of glucose sodium-cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on the incidence of cardiovascular events in patients with type...
20.
Gatta G, Somma F, Sardu C, De Chiara M, Massafra R, Fanizzi A, et al.
J Pers Med
. 2023 Dec;
13(12).
PMID: 38138910
: The purpose of this meta-analysis is to investigate the effectiveness of supplementing screening mammography with three-dimensional automated breast ultrasonography (3D ABUS) in improving breast cancer detection rates in asymptomatic...